Grants per year
Search results
-
Active
SB-913-1603: A Phase I, Multicenter, Open-label, Single-dose, Dose-ranging Study to Assess the Safety and Tolerability of SB-913, a rAAV2/6-based Gene Transfer in Subjects with Mucopolysaccharidosis II (MPS II)
Alden, T. D. (PD/PI), Burton, B. K. (PD/PI) & Mohammad, S. (PD/PI)
9/1/17 → 8/31/50
Project: Research project
-
The Park-Reeves Syringomyelia Registry and Data Use Agreement
Alden, T. D. (PD/PI), DiPatri, A. J. (PD/PI) & Tomita, T. (PD/PI)
1/18/13 → 8/31/50
Project: Research project